{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:17:01Z","timestamp":1785403021850,"version":"3.56.0"},"reference-count":24,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Charlies Research Foundation","award":["2015-16\/047"],"award-info":[{"award-number":["2015-16\/047"]}]},{"name":"Geriatric Medicine Departmental staff at Sir Charles Gairdner Hospital"},{"id":[{"id":"https:\/\/ror.org\/01hhqsm59","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Osborne Park Hospital"},{"id":[{"id":"https:\/\/ror.org\/04v8sjw26","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Fremantle Hospital"},{"id":[{"id":"https:\/\/ror.org\/03yxgmm62","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Armadale Hospital"},{"id":[{"id":"https:\/\/ror.org\/01nkdyf86","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Joondalup Health Campus"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objectives: Dementia and osteoporosis are common and debilitating conditions that often coexist in older adults. We investigated mortality in patients with and without dementia as the primary outcome in a prospective memory clinic cohort. Falls and fractures were assessed as secondary outcomes, and associations with baseline acetylcholinesterase inhibitor (AChEI) use were explored. Methods: In a prospective observational cohort study, data were collected during routine clinical visits over four years. Data included demographics, dementia diagnosis, AChEI use, falls, fractures, bone mineral density (BMD) when clinically available, and mortality. Analysis included chi-square tests, Kaplan\u2013Meier survival curves, Cox proportional hazards models, and recurrent-event models. Because AChEI analyses were exploratory and included several related endpoints, Benjamini\u2013Hochberg false discovery rate (FDR) correction was applied to endpoint-level AChEI p-values. Results: 744 patients were enrolled; the mean age was 80.99 \u00b1 6.8 years; 58.5% female; 55.8% with dementia. AChEI use was recorded in 113 patients (15.2%) at baseline. Over 4 years, 16.61% of participants experienced at least one fall with a cumulative fracture risk of 30.90%. Mortality was significantly higher in dementia patients (44.58% vs. 27.05%; p &lt; 0.001). Dementia patients had double the mortality risk (OR: 1.956; 95% CI: 1.425\u20132.686). Annual and cumulative mortality rates increased progressively from 5.51% and in year 1 to 17.69% and 36.83% respectively by year 4. Baseline AChEI use was not significantly associated with mortality. Risk\/100 for patient with dementia vs. without dementia for falls was 4.04 vs. 4.32 and fracture was 4.37 vs. 3.01. AChEI users had a trend of lower incidence\/100 patient-years for falls of 3.01 vs. 4.37 and fractures 6.78 vs. 10.09. Conclusions: Dementia patients have higher mortality risk but not falls or fracture risk in this cohort. Although clinical cohort and animal studies suggest a benefit for AChEIs, this was not evident in this study possibly due to clinical cohort limitations. The trend of reduced falls and fracture in the AChEI cohort warrants further study.<\/jats:p>","DOI":"10.3390\/jcm15145390","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:17:51Z","timestamp":1783606671000},"page":"5390","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dementia and the Impact of Acetylcholinesterase Inhibitors on Falls, Fractures and Mortality in a Geriatric Cohort: A 4-Year Follow-Up Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0535-963X","authenticated-orcid":false,"given":"Charles","family":"Inderjeeth","sequence":"first","affiliation":[{"name":"Geriatric, Acute and Rehabilitation Medicine (GARM), Sir Charles Gairdner Osborne Park Health Care Group, Hospital Avenue, Perth, WA 6009, Australia"},{"name":"School of Medicine, University of Western Australia, Crawley, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diren Che","family":"Inderjeeth","sequence":"additional","affiliation":[{"name":"Geriatric, Acute and Rehabilitation Medicine (GARM), Sir Charles Gairdner Osborne Park Health Care Group, Hospital Avenue, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Bharadwaj","sequence":"additional","affiliation":[{"name":"Fremantle Hospital, South Terrace, Perth, WA 6160, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3209-1976","authenticated-orcid":false,"given":"Dani","family":"Kostova","sequence":"additional","affiliation":[{"name":"Geriatric, Acute and Rehabilitation Medicine (GARM), Sir Charles Gairdner Osborne Park Health Care Group, Hospital Avenue, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Tillman","sequence":"additional","affiliation":[{"name":"Geriatric, Acute and Rehabilitation Medicine (GARM), Sir Charles Gairdner Osborne Park Health Care Group, Hospital Avenue, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mei","sequence":"additional","affiliation":[{"name":"Geriatric, Acute and Rehabilitation Medicine (GARM), Sir Charles Gairdner Osborne Park Health Care Group, Hospital Avenue, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Isbel","sequence":"additional","affiliation":[{"name":"Geriatric, Acute and Rehabilitation Medicine (GARM), Sir Charles Gairdner Osborne Park Health Care Group, Hospital Avenue, Perth, WA 6009, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref_1","unstructured":"Australian Bureau of Statistics (2025, November 24). Arthritis and Osteoporosis in Australia: A Snapshot, 2007\u201308, Available online: https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Latestproducts\/4843.0.55.001Main%20Features."},{"key":"ref_2","unstructured":"Watts, J., Abimanyi-Ochom, J., and Sanders, K. (2013). Osteoporosis Costing All Australians, 2012\u20132022: A New Burden of Disease Analysis, Osteoporosis Australia."},{"key":"ref_3","unstructured":"Australian Institute of Health and Welfare (2026, January 18). Dementia in Australia, Available online: https:\/\/www.aihw.gov.au\/reports\/dementia\/dementia-in-aus\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.31128\/AJGP-04-18-4544","article-title":"Osteoporosis in Patients with Dementia Is Associated with High Morbidity and Mortality: Findings from a Single Orthogeriatric Unit","volume":"48","author":"Mughal","year":"2019","journal-title":"Aust. J. Gen. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00198-011-1636-8","article-title":"Undertreatment of Osteoporosis in Persons with Dementia? A Population-Based Study","volume":"23","author":"Haasum","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2010-101467","article-title":"Association between Bone Mineral Density and the Risk of Alzheimer\u2019s Disease","volume":"24","author":"Zhou","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40520-024-02871-y","article-title":"Impact of Dementia and Mild Cognitive Impairment on Bone Health in Older People","volume":"37","author":"Curtis","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_8","first-page":"124","article-title":"Cholinergic Regulation of Bone","volume":"13","author":"Eimar","year":"2013","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1002\/alz.13864","article-title":"Crosstalk between Bone and Brain in Alzheimer\u2019s Disease: Mechanisms, Applications, and Perspectives","volume":"20","author":"Liu","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000242444","article-title":"High Incidence of Osteoporosis and Fractures in an Aging Post-Polio Population","volume":"62","author":"Mohammad","year":"2009","journal-title":"Eur. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1196\/annals.1402.009","article-title":"Bone Loss after Temporarily Induced Muscle Paralysis by Botox Is Not Fully Recovered After 12 Weeks","volume":"1116","author":"Grimston","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bone.2005.08.009","article-title":"Botox Induced Muscle Paralysis Rapidly Degrades Bone","volume":"38","author":"Warner","year":"2006","journal-title":"Bone"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Birks, J.S. (2006). Cholinesterase Inhibitors for Alzheimer\u2019s Disease. Cochrane Database Syst. Rev., CD005593.","DOI":"10.1002\/14651858.CD005593"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A Review on Cholinesterase Inhibitors for Alzheimer\u2019s Disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/jbmr.1616","article-title":"Acetylcholinesterase Inhibitors and the Risk of Hip Fracture in Alzheimer\u2019s Disease Patients: A Case-Control Study","volume":"27","author":"Tamimi","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/jcp.31057","article-title":"Antidementia Medication Acetylcholinesterase Inhibitors Have Therapeutic Benefits on Osteoporotic Bone by Attenuating Osteoclastogenesis and Bone Resorption","volume":"238","author":"Li","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14283\/jpad.2023.61","article-title":"Burden of Illness in People with Alzheimer\u2019s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality","volume":"11","author":"Eichinger","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Ramos, J.J., Gonz\u00e1lez-Guerra, M., D\u00e1valos-Rodr\u00edguez, I.P., P\u00e9rez-Ru\u00edz, M.E., Pe\u00f1a-Dur\u00e1n, E., and Mar\u00edn-Medina, A. (2024). Geriatric Syndromes and Their Relationship with Mortality in a Population of Mexican Older Adults Aged 65 and Over, Admitted to the Emergency Department of a Second-Level Care Hospital. Healthcare, 12.","DOI":"10.3390\/healthcare12121166"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2024402","DOI":"10.1590\/1516-3180.2024.0402.r1.24032025","article-title":"Determinants of Mortality Risk in Older Adults from the ELSIA Study: A Prospective Cohort Study","volume":"143","author":"Santos","year":"2025","journal-title":"Sao Paulo Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1519\/JPT.0000000000000386","article-title":"Older Adults with Alzheimer\u2019s Disease Have Lower Bone Mineral Density Compared to Older Adults Without Dementia: A Systematic Review with Meta-Analysis of Observational Studies","volume":"47","author":"Cezar","year":"2024","journal-title":"J. Geriatr. Phys. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/MS9.0000000000001721","article-title":"The Risk of Bone Fractures in Dementia Patients Receiving Acetylcholinesterase Inhibitors: A Meta-Analysis","volume":"86","author":"Elhalag","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.trci.2019.07.011","article-title":"Are Antidementia Drugs Associated with Reduced Mortality after a Hospital Emergency Admission in the Population with Dementia Aged 65 Years and Older?","volume":"5","author":"Hapca","year":"2019","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/TCRM.S323387","article-title":"Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review","volume":"17","author":"Ruangritchankul","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Moon, A., Jang, S., Kim, J.-H., and Jang, S. (2024). Risk of Falls or Fall-Related Injuries Associated with Potentially Inappropriate Medication Use among Older Adults with Dementia. BMC Geriatr., 24.","DOI":"10.1186\/s12877-024-05300-x"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5390\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:31:24Z","timestamp":1783607484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":24,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15145390"],"URL":"https:\/\/doi.org\/10.3390\/jcm15145390","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}